Omega Healthcare (OHI) President Awarded Equity Grant
OMEGA HEALTHCARE INVESTORS INC
Subscribe to track OHI
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Omega Healthcare (OHI) President Awarded Equity Grant
Company: OMEGA HEALTHCARE INVESTORS INC (OHI) Form: 4 | Filed: 2026/01/15 Significance: Low
Insider: Gourmand Matthew Paul Title: President | Relationship: Officer
Transaction: • Type: Grant • Shares: 42,805 (Profits Interest Units) • Price: $0.00 • Value: $0 • Owned After: 160,767 (Derivative Securities)
Key Insight: The President received a routine equity grant of 42,805 Profits Interest Units, convertible into common stock upon vesting. This is a standard form of non-cash compensation.
Market Context: The grant represents a potential dilution of approximately 0.015% of shares outstanding, a negligible amount for a $12.99 billion company. This is a routine executive compensation event with no immediate market impact.
Comprehensive Analysis
SEC Filing Analysis: OMEGA HEALTHCARE INVESTORS INC (OHI)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The President of Omega Healthcare, Matthew Paul Gourmand, received a routine equity grant of 42,805 Profits Interest Units as part of a standard compensation package.
- Market Impact: Neutral. This is a non-market transaction with negligible dilutive effect and does not signal any new information about the company's performance.
Company Information
| Field | Value |
|---|---|
| Company | OMEGA HEALTHCARE INVESTORS INC |
| Ticker Symbol | OHI |
| CIK | 0000888491 |
| Industry | REAL ESTATE INVESTMENT TRUSTS |
Insider Information
| Field | Value |
|---|---|
| Name | Gourmand Matthew Paul |
| CIK | 0002051270 |
| Title/Position | President |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2026-01-13 |
| Transaction Code | A (Award) |
| Security Type | Profits Interest Units |
| Shares Involved | 42,805 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 160,767 (Derivative Securities) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
Note: The provided shares outstanding of 295,000 is inconsistent with a $12.99B market cap. Analysis assumes a more realistic 295,000,000 shares outstanding.
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.0% |
| Shares Transacted | 42,805 |
| % of Shares Outstanding | ~0.015% |
| Post-Transaction Ownership | 160,767 derivative securities |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a large-cap company valued at $12.99 billion, this grant is financially immaterial.
- Ownership Concentration: The insider's total potential holdings from these derivative securities represent a very small fraction of the company's total shares.
- Dilution Impact: The potential dilution from these 42,805 units is approximately 0.015%, which is a negligible impact on existing shareholders and is a standard cost of executive compensation.
- Transaction Significance: The significance is low. This is a pre-planned, non-cash compensation award, not an open-market transaction reflecting insider sentiment.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants are a routine part of executive compensation and do not provide new information to the market that would influence the stock price.
Volume & Sentiment
- Expected Volume Impact: None. This was not an open-market trade.
- Sentiment Indicator: Neutral. This filing is informational regarding compensation and does not carry a bullish or bearish signal.
Additional Context
Transaction Notes
- Security Type: The securities are Profits Interest Units (PIUs), which are convertible into common stock on a one-for-one basis.
- Vesting Schedule: The grant is subject to a three-year vesting cliff, meaning the shares will not be accessible to the insider until December 31, 2028, contingent on continued employment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
